US Physical Therapy USPH Business Combination Acquisition Fair Value Of Redeemable Non Controlling Interests

Discontinued — last reported Q2 '18

Segments

Physical Therapy Operations$6.17M+188%

Revenue$198.3M+7.9%

Gross profit$32.8M+5.4%

Operating income$12.5M-36.5%

Net income$5.0M-49.1%

EPS (diluted)-$0.12-115%

Cash & equivalents$28.4M-27.4%

Total debt$169.4M+12.6%

Total equity$469.0M-5.7%

Total assets$1.2B+5.3%

Operating cash flow$3.8M+181%

CapEx$5.4M+108%

Free cash flow-$1.6M+78.4%

Market cap$1.01B-10.6%

Enterprise value$1.15B-7.2%

P/E29.1×-4.8×

P/S1.3×-0.3×

Gross margin19%+0.9pp

Operating margin10%+0.3pp

Net margin4.4%-0.4pp

FCF margin8.4%+0.4pp

Return on equity7.2%+0.4pp

Debt / equity0.4×+0.1×

Current ratio1.2×0.0×

Reported directly by US Physical Therapy in its filing.

Tagged under the XBRL concept usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests.

The official record: US Physical Therapy’s 10-Q, filed November 8, 2019, on SEC EDGAR. View the filing →